纖維蛋白原結(jié)合抑制劑肽
| 中文名稱 | 纖維蛋白原結(jié)合抑制劑肽 |
|---|---|
| 中文同義詞 | HV-12;L-纈氨酸,L-組氨酰-L-組氨酰-L-亮氨酰甘氨酰甘氨酰-L-丙氨酰-L-賴氨酰-L-谷酰;纖維蛋白原結(jié)合抑制劑肽;纖維蛋白原結(jié)合抑制肽 |
| 英文名稱 | HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL |
| 英文同義詞 | FIBRINOGEN Y-CHAIN DODECAPETIDE;FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE;FIBRINOGEN-BINDING INHIBITOR PEPTIDE;HUMAN FIBRINOGEN-GAMMA FRAGMENT 400-411;HHLGGAKQAGDV;H-HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL-OH;HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL;fibrinogen-γ fragment 400-411 |
| CAS號(hào) | 89105-94-2 |
| 分子式 | C50H80N18O16 |
| 分子量 | 1189.28 |
| EINECS號(hào) | |
| 相關(guān)類別 | 多肽;目錄多肽;peptide |
| Mol文件 | 89105-94-2.mol |
| 結(jié)構(gòu)式 | ![]() |
纖維蛋白原結(jié)合抑制劑肽 性質(zhì)
| 沸點(diǎn) | 1809.9±65.0 °C(Predicted) |
|---|---|
| 密度 | 1.342±0.06 g/cm3(Predicted) |
| 儲(chǔ)存條件 | −20°C |
| 形態(tài) | 固體 |
| 酸度系數(shù)(pKa) | 3.20±0.10(Predicted) |
| 顏色 | 白色至米白色 |
| 序列 | H-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val-OH |
Glycoprotein (GP) IIb/IIIa, which exists on the membrane of platelets, changes its form from inactive to active when platelets adhere to collagen exposed on sites of vascular injury. In the circulation, platelet aggregation is mediated by fibrinogen by bridging adjacent platelets through GPIIb/IIIa in an activation-dependent manner. A dodecapeptide HHLGGAKQAGDV (H12), corresponding to the fibrinogen γ-chain carboxy-terminal sequence (γ400-411), is a specific binding site of the ligand for activated GPIIb/IIIa
純度(HPLC) ≥98.0%
醋酸根含量≤12.0%
水分含量≤8.0%
肽含量≥80.0%
內(nèi)毒素≤50EU/mg
氨基酸組成分析≤±10%
安全信息
| WGK Germany | 3 |
|---|
| 提供商 | 語(yǔ)言 |
|---|---|
|
英文
|
| 更新日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
|---|---|---|---|---|---|
| 2026/06/05 | HY-P1507 | FIBRINOGEN-BINDING INHIBITOR PEPTIDE Fibrinogen Binding Inhibitor Peptide | 89105-94-2 | 1mg | 800元 |
| 2026/06/05 | HY-P1507 | FIBRINOGEN-BINDING INHIBITOR PEPTIDE Fibrinogen Binding Inhibitor Peptide | 89105-94-2 | 5mg | 1900元 |
